Scientific Reports (May 2022)

Altered epithelial barrier functions in the colon of patients with spina bifida

  • Charlène Brochard,
  • Guillaume Bouguen,
  • Raphael Olivier,
  • Tony Durand,
  • Sébastien Henno,
  • Benoît Peyronnet,
  • Mael Pagenault,
  • Chloé Lefèvre,
  • Gaëlle Boudry,
  • Mikael Croyal,
  • Alain Fautrel,
  • Maxime Esvan,
  • Alain Ropert,
  • Anne Dariel,
  • Laurent Siproudhis,
  • Michel Neunlist

DOI
https://doi.org/10.1038/s41598-022-11289-3
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 12

Abstract

Read online

Abstract Our objectives were to better characterize the colorectal function of patients with Spina Bifida (SB). Patients with SB and healthy volunteers (HVs) completed prospectively a standardized questionnaire, clinical evaluation, rectal barostat, colonoscopy with biopsies and faecal collection. The data from 36 adults with SB (age: 38.8 [34.1–47.2]) were compared with those of 16 HVs (age: 39.0 [31.0–46.5]). Compared to HVs, rectal compliance was lower in patients with SB (p = 0.01), whereas rectal tone was higher (p = 0.0015). Ex vivo paracellular permeability was increased in patients with SB (p = 0.0008) and inversely correlated with rectal compliance (r = − 0.563, p = 0.002). The expression of key tight junction proteins and inflammatory markers was comparable between SB and HVs, except for an increase in Claudin-1 immunoreactivity (p = 0.04) in SB compared to HVs. TGFβ1 and GDNF mRNAs were expressed at higher levels in patients with SB (p = 0.02 and p = 0.008). The levels of acetate, propionate and butyrate in faecal samples were reduced (p = 0.04, p = 0.01, and p = 0.02, respectively). Our findings provide evidence that anorectal and epithelial functions are altered in patients with SB. The alterations in these key functions might represent new therapeutic targets, in particular using microbiota-derived approaches. Clinical Trials: NCT02440984 and NCT03054415.